Table 1.
Correlation between METTL3 expression and clinicopathological characteristics in 100 cases from our center
| Characters | Weak/moderate staining N = 48 | Strong staining N = 52 | P values |
|---|---|---|---|
| Age, year | |||
| ≥50 | 30 | 28 | 0.422 |
| ＜50 | 18 | 24 | |
| Gender | |||
| Male | 32 | 32 | 0.678 |
| Female | 16 | 20 | |
| Etiology | |||
| HBV/HCV | 36 | 37 | 0.822 |
| No‐viral | 12 | 15 | |
| T stage | |||
| T1/T2 | 33 | 27 | 0.104 |
| T3/T4 | 15 | 25 | |
| Grade | |||
| G1/G2 | 30 | 20 | 0.028 |
| G3/G4 | 18 | 32 | |
| Cirrhosis | |||
| Yes | 28 | 29 | 0.842 |
| No | 20 | 23 | |
| TNM staging | |||
| I/II | 33 | 26 | 0.069 |
| III/IV | 15 | 26 | |
| AFP | |||
| >200 μg/L | 22 | 31 | 0.229 |
| ≤200 μg/L | 26 | 21 | |
Abbreviations: HBV, Hepatitis B Virus; HCV, Hepatitis C Virus; AFP, alpha‐fetoprotein.
TNM staging, the AJCC 8th edition.